These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36633470)

  • 21. Terlipressin in hepatorenal syndrome: Evidence for present indications.
    Rajekar H; Chawla Y
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
    Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
    Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function.
    Huang X; Bindra J; Chopra I; Niewoehner J; Wan GJ
    Adv Ther; 2023 Dec; 40(12):5432-5446. PubMed ID: 37812332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of patients with hepatorenal syndrome undergoing liver transplantation in the era of terlipressin.
    Terbah R; Cao J; Wong D; Lim PCH; Gow P; Testro A; Sinclair M
    Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):881-888. PubMed ID: 37395241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico.
    Muñoz LE; Alcalá EG; Cordero P; Martínez MA; Vázquez NY; Galindo S; Mendoza E; Segura JJ
    Ann Hepatol; 2009; 8(3):207-11. PubMed ID: 19841499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence.
    Zhang J; Rössle M; Zhou X; Deng J; Liu L; Qi X
    Curr Med Res Opin; 2019 May; 35(5):859-868. PubMed ID: 30474439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.
    Belcher JM; Parada XV; Simonetto DA; Juncos LA; Karakala N; Wadei HM; Sharma P; Regner KR; Nadim MK; Garcia-Tsao G; Velez JCQ; Parikh SM; Chung RT; Allegretti AS;
    Am J Kidney Dis; 2022 May; 79(5):737-745. PubMed ID: 34606933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noradrenaline is as Effective as Terlipressin in Hepatorenal Syndrome Type 1: A Prospective, Randomized Trial.
    Goyal O; Sidhu SS; Sehgal N; Puri S
    J Assoc Physicians India; 2016 Sep; 64(9):30-35. PubMed ID: 27762512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2.
    Nguyen-Tat M; Jäger J; Rey JW; Nagel M; Labenz C; Wörns MA; Galle PR; Marquardt JU
    United European Gastroenterol J; 2019 May; 7(4):529-537. PubMed ID: 31065370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.
    Ghosh S; Choudhary NS; Sharma AK; Singh B; Kumar P; Agarwal R; Sharma N; Bhalla A; Chawla YK; Singh V
    Liver Int; 2013 Sep; 33(8):1187-93. PubMed ID: 23601499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Piano S; Gambino C; Vettore E; Calvino V; Tonon M; Boccagni P; Gringeri E; Germani G; Burra P; Cillo U; Angeli P
    Hepatology; 2021 May; 73(5):1909-1919. PubMed ID: 32870499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI).
    Kulkarni AV; Lee J; Reddy KR
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1067-1079. PubMed ID: 37856367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.
    Magan AA; Khalil AA; Ahmed MH
    World J Gastroenterol; 2010 Nov; 16(41):5139-47. PubMed ID: 21049548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study.
    Narahara Y; Kanazawa H; Sakamoto C; Maruyama H; Yokosuka O; Mochida S; Uemura M; Fukui H; Sumino Y; Matsuzaki Y; Masaki N; Kokubu S; Okita K
    J Gastroenterol; 2012 Mar; 47(3):313-20. PubMed ID: 22038555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome.
    Krishna R; Raj J; Dev D; Prasad SC; Reghu R; V SO
    Scand J Gastroenterol; 2020 Jul; 55(7):860-864. PubMed ID: 32634332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terlipressin in hepatorenal syndrome.
    Mazur JE; Cooper TB; Dasta JF
    Ann Pharmacother; 2011 Mar; 45(3):380-7. PubMed ID: 21386023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
    Wang H; Liu A; Bo W; Feng X; Hu Y
    Medicine (Baltimore); 2018 Apr; 97(16):e0431. PubMed ID: 29668606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis.
    Malik A; Malik MI; Qureshi S; Nadir A
    Ann Hepatol; 2024; 29(4):101495. PubMed ID: 38460713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: A randomized controlled study.
    Saif RU; Dar HA; Sofi SM; Andrabi MS; Javid G; Zargar SA
    Indian J Gastroenterol; 2018 Sep; 37(5):424-429. PubMed ID: 30178092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.